State of Wisconsin Investment Board’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-48,718
| Closed | -$2.31M | – | 2372 |
|
|
2025
Q3 | $2.31M | Buy |
48,718
+15,172
| +45% | +$735K | 0.01% | 1305 |
|
|
2025
Q2 | $1.79M | Sell |
33,546
-3,594
| -10% | -$163K | ﹤0.01% | 1352 |
|
|
2025
Q1 | $1.5M | Buy |
37,140
+1,729
| +5% | +$73.3K | ﹤0.01% | 1348 |
|
|
2024
Q4 | $985K | Buy |
35,411
+7,857
| +29% | +$238K | ﹤0.01% | 1532 |
|
|
2024
Q3 | $791K | Sell |
27,554
-3,400
| -11% | -$88.6K | ﹤0.01% | 1659 |
|
|
2024
Q2 | $726K | Sell |
30,954
-1,827
| -6% | -$39.1K | ﹤0.01% | 1658 |
|
|
2024
Q1 | $828K | Sell |
32,781
-33,152
| -50% | -$796K | ﹤0.01% | 1490 |
|
|
2023
Q4 | $1.54M | Buy |
65,933
+14,347
| +28% | +$283K | ﹤0.01% | 1290 |
|
|
2023
Q3 | $2.61M | Buy |
51,586
+10,300
| +25% | +$480K | 0.01% | 1171 |
|
|
2023
Q2 | $1.93M | Buy |
41,286
+11,167
| +37% | +$512K | 0.01% | 1301 |
|
|
2023
Q1 | $1.15M | Buy |
30,119
+1,451
| +5% | +$64.7K | ﹤0.01% | 1439 |
|
|
2022
Q4 | $1.57M | Buy |
28,668
+10,087
| +54% | +$432K | 0.01% | 1375 |
|
|
2022
Q3 | $633K | Buy |
18,581
+415
| +2% | +$6.35K | ﹤0.01% | 1840 |
|
|
2022
Q2 | $172K | Sell |
18,166
-15,134
| -45% | -$158K | ﹤0.01% | 2540 |
|
|
2022
Q1 | $473K | Hold |
33,300
| – | – | ﹤0.01% | 1950 |
|
|
2021
Q4 | $704K | Hold |
33,300
| – | – | ﹤0.01% | 1559 |
|
|
2021
Q3 | $744K | Hold |
33,300
| – | – | ﹤0.01% | 1549 |
|
|
2021
Q2 | $826K | Buy |
33,300
+15,100
| +83% | +$424K | ﹤0.01% | 1510 |
|
|
2021
Q1 | $528K | Sell |
18,200
-800
| -4% | -$24.2K | ﹤0.01% | 1580 |
|
|
2020
Q4 | $490K | Buy |
19,000
+6,100
| +47% | +$170K | ﹤0.01% | 1547 |
|
|
2020
Q3 | $397K | Hold |
12,900
| – | – | ﹤0.01% | 1558 |
|
|
2020
Q2 | $321K | Hold |
12,900
| – | – | ﹤0.01% | 1541 |
|
|
2020
Q1 | $273K | Buy |
+12,900
| New | +$277K | ﹤0.01% | 1522 |
|
Other funds holding AKRO
State of Wisconsin Investment Board's AKRO Position: Q4 2025 in Review
State of Wisconsin Investment Board sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 48,718 shares — an estimated $2.31M sold.
State of Wisconsin Investment Board first reported a position in AKRO in Q1 2020 and held it in 23 quarters. The position peaked at $2.61M in Q3 2023. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.
- State of Wisconsin Investment Board reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
- State of Wisconsin Investment Board sold 48,718 Akero Therapeutics shares in Q4 2025, an estimated $2.31M.
- State of Wisconsin Investment Board first reported a position in Akero Therapeutics in Q1 2020 and held it in 23 quarters.
- State of Wisconsin Investment Board's Akero Therapeutics position peaked at $2.61M in Q3 2023.
- 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.
Based on State of Wisconsin Investment Board's 13F filing for Q4 2025, filed 17 Feb 2026.